Home » Topics » BioWorld

BioWorld
RSS

ARCTURUS RAISES $3.5 MILLION

July 24, 1992

MMD EXTENDS PACT WITH AFFYMAX

July 24, 1992

IMMUNEX, HOECHST BURY THE HATCHET

July 24, 1992

EYE TREATMENT ENTERS PHASE III

July 24, 1992

CAMBRIDGE BIOTECH FORMS JOINT VENTURE

July 24, 1992

CYTRX BURN DRUG ENTERS PHASE II

July 24, 1992

PATCH SALES IGNITE ALZA REVENUES

July 23, 1992

ROCHE GETS HIV TESTING PERMITS IN NEW YORK

July 23, 1992

DYNAGEN AMENDS OFFERING

July 23, 1992

AMGEN STOCK HITS FOUR-MONTH HIGH

July 23, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...